BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37758792)

  • 1. A pancancer analysis of the oncogenic role of cyclin B1 (CCNB1) in human tumors.
    Dai P; Xiong L; Wei Y; Wei X; Zhou X; Zhao J; Tang H
    Sci Rep; 2023 Sep; 13(1):16226. PubMed ID: 37758792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-139-5p Targeting CCNB1 Modulates Proliferation, Migration, Invasion and Cell Cycle in Lung Adenocarcinoma.
    Bao B; Yu X; Zheng W
    Mol Biotechnol; 2022 Aug; 64(8):852-860. PubMed ID: 35181869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of CCNB1 driven by ncRNAs is associated with a poor prognosis and tumor immune infiltration in breast cancer.
    Fu H; Li K; Wang S; Li Y
    Aging (Albany NY); 2022 Aug; 14(16):6780-6795. PubMed ID: 36040381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1.
    Chai N; Xie HH; Yin JP; Sa KD; Guo Y; Wang M; Liu J; Zhang XF; Zhang X; Yin H; Nie YZ; Wu KC; Yang AG; Zhang R
    Biochem Biophys Res Commun; 2018 Jun; 500(4):924-929. PubMed ID: 29705704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma.
    Zou Y; Ruan S; Jin L; Chen Z; Han H; Zhang Y; Jian Z; Lin Y; Shi N; Jin H
    Med Sci Monit; 2020 Aug; 26():e925289. PubMed ID: 32863381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YTHDF1 Promotes Cyclin B1 Translation through m
    Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of Cyclin B1 by miRNA and its implications in cancer.
    Huang V; Place RF; Portnoy V; Wang J; Qi Z; Jia Z; Yu A; Shuman M; Yu J; Li LC
    Nucleic Acids Res; 2012 Feb; 40(4):1695-707. PubMed ID: 22053081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
    Yang X; Zhou S; Yang C; Cao C; He M; Zi S
    Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA‑718 serves a tumor‑suppressive role in non‑small cell lung cancer by directly targeting CCNB1.
    Wang S; Sun H; Zhan X; Wang Q
    Int J Mol Med; 2020 Jan; 45(1):33-44. PubMed ID: 31746372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCNB1 is a novel prognostic biomarker and promotes proliferation, migration and invasion in Wilms tumor.
    Xiang B; Chen ML; Gao ZQ; Mi T; Shi QL; Dong JJ; Tian XM; Liu F; Wei GH
    BMC Med Genomics; 2023 Aug; 16(1):189. PubMed ID: 37592341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin B1 acts as a tumor microenvironment-related cancer promoter and prognostic biomarker in hepatocellular carcinoma.
    Hou Y; Wang X; Wang J; Sun X; Liu X; Hu H; Fan W; Zhang X; Wu D
    J Int Med Res; 2021 May; 49(5):3000605211016265. PubMed ID: 34044639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression.
    Bai X; Wang W; Zhao P; Wen J; Guo X; Shen T; Shen J; Yang X
    Carcinogenesis; 2020 Mar; 41(1):111-121. PubMed ID: 31605132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin B1: A potential prognostic and immunological biomarker in pan-cancer.
    Chen Q; Ouyang L; Liu Q
    Biomol Biomed; 2024 Apr; ():. PubMed ID: 38581717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of cyclin B1 in solid tumors: a meta-analysis.
    Ye C; Wang J; Wu P; Li X; Chai Y
    Oncotarget; 2017 Jan; 8(2):2224-2232. PubMed ID: 27903976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
    Agarwal R; Gonzalez-Angulo AM; Myhre S; Carey M; Lee JS; Overgaard J; Alsner J; Stemke-Hale K; Lluch A; Neve RM; Kuo WL; Sorlie T; Sahin A; Valero V; Keyomarsi K; Gray JW; Borresen-Dale AL; Mills GB; Hennessy BT
    Clin Cancer Res; 2009 Jun; 15(11):3654-62. PubMed ID: 19470724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CCNB1, CENPF, and neutrophils in lung cancer diagnosis and prognosis.
    Tan F; Tang Y; He Z
    Medicine (Baltimore); 2023 Nov; 102(46):e35802. PubMed ID: 37986322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis.
    Chen EB; Qin X; Peng K; Li Q; Tang C; Wei YC; Yu S; Gan L; Liu TS
    Aging (Albany NY); 2019 Sep; 11(18):7473-7491. PubMed ID: 31527303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chk1-induced CCNB1 overexpression promotes cell proliferation and tumor growth in human colorectal cancer.
    Fang Y; Yu H; Liang X; Xu J; Cai X
    Cancer Biol Ther; 2014 Sep; 15(9):1268-79. PubMed ID: 24971465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEOX1 suppresses the progression of lung cancer cells by inhibiting the cell-cycle checkpoint gene CCNB1.
    Xiao X; Rui B; Rui H; Ju M; Hongtao L
    Environ Toxicol; 2022 Mar; 37(3):504-513. PubMed ID: 34837450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The LncRNA EPEL Promotes Lung Cancer Cell Proliferation Through E2F Target Activation.
    Park SM; Choi EY; Bae DH; Sohn HA; Kim SY; Kim YJ
    Cell Physiol Biochem; 2018; 45(3):1270-1283. PubMed ID: 29448242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.